ANTI-VEGF ANTIBODY, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING, DIAGNOSING OR TREATING CANCER OR ANGIOGENESIS-RELATED DISEASES, CONTAINING SAME

摘要

The present invention relates to: a novel anti-vascular endothelial growth factor (VEGF) antibody having a strong binding affinity to VEGF and capable of inhibiting in vivo tumor growth; and a composition for treating cancer, containing the same. The antibody of the present invention shows a remarkable binding property to human and mouse VEGF, inhibits the proliferation and permeability of a human umbilical vein endothelial cell (HUVEC) and can suppress tumor growth, and thus can be useful as an antibody for treating cancer.